Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | -3.71% | +12.56% | +14.91% |
06/06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
05/06 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.91% | 163Cr | |
+52.31% | 5.93TCr | |
+42.15% | 4.09TCr | |
-5.58% | 4.02TCr | |
-5.56% | 2.87TCr | |
+10.49% | 2.66TCr | |
-21.37% | 1.89TCr | |
+30.04% | 1.25TCr | |
+1.23% | 1.24TCr | |
+27.21% | 1.23TCr |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Baird Downgrades Vir Biotechnology to Underperform From Neutral; Price Target is $36